Grady Memorial Hospital — Atlanta, Georgia

Public research footprint of Grady Memorial Hospital, compiled from the ClinicalTrials.gov public registry.

443

Registered studies

141

Active

Recruiting now

238

Completed

Stopped or withdrawn

Most-studied conditions

Recurrent Platinum-Resistant Ovarian Carcinoma · Stage IV Cutaneous Melanoma AJCC v6 and v7 · Recurrent Primary Peritoneal High Grade Serous Adenocarcinoma · EBV-Positive Diffuse Large B-Cell Lymphoma, Not Otherwise Specified

Recently updated registry entries

NCT04181060 — Osimertinib With or Without Bevacizumab as Initial Treatment for Patients With… (Recruiting)
NCT05812807 — Pembrolizumab vs. Observation in People With Triple-negative Breast Cancer Who Had a… (Recruiting)
NCT06058377 — Adding an Immunotherapy Drug, MEDI4736 (Durvalumab), to the Usual Chemotherapy Treatment… (Recruiting)

7 more recent registry entries at this facility

Enter your work email to view the full list.

I’d also like to receive occasional marketing emails from Eichor for research sites (optional — unsubscribe anytime).

Work at Grady Memorial Hospital?

Verify and correct how your facility appears in public registry records — free.

Verify this profile →

Compiled from public registry records (ClinicalTrials.gov) as of August 05, 2026. Counts reflect how this facility appears in registry listings; name variants may exist and are not combined. This page describes public records only and makes no assessment of any facility.